Last March, famed investor Warren Buffett’s No. 2, Charlie Munger, took a shot at , the drug company with a voracious appetite for deals, and its now-outgoing chief executive Michael Pearson. ​“Valeant is like and Harold Geneen come back to life, only the guy is worse this time,” Munger said, referring to the now busted-up […]